Limitations, agreements, and source contact

Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma · Source last updated 2014-05-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

LTE60

restrictive Agreement

true

point Of Contact

email

tapw@mskcc.org

organization

Memorial Sloan-Kettering Cancer Center

phone

646-888-4163

title

Dr. William Tap

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice